Novi review
Two molecules, one former price
Semaglutide at $99 and tirzepatide at $133 are both discounts struck against the same $299 figure.
Our verdict
Novi prices two molecules and gives both the same origin story: was $299, now starting at $99 for semaglutide and $133 for tirzepatide. A single former price covering two drugs of very different market cost is a marketing device rather than a price history, and a buyer should read it that way. What sits underneath it is genuinely clean — the rate is stated as flat at every dose, there is no membership fee charged outside the medication price, and the plan can be canceled at any time. Those three conditions are what usually break a low headline figure by month three, and Novi closes all three. The words starting at remain the qualifier that has not been quantified.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $99/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Updated
- September 2026
What it is
A telehealth seller offering compounded semaglutide and compounded tirzepatide as weekly injections, priced flat across doses and sold without a membership.
How it works
A prescription-gated online program: the medication price is charged directly, with no separate membership or program fee attached to it, and the plan can be canceled at any time. Dose changes do not change the price.
Pricing transparency
Compounded semaglutide is advertised at $99 a month and compounded tirzepatide at $133 a month, each presented as a reduction from a $299 rate. Both are stated to be flat at every dose, with no membership fee and cancellation available at any time. Both carry the qualifier starting at, which leaves open whether some configuration costs more. The $34 gap between the two molecules is narrow for a pair that usually separates by a much wider margin.
Branded vs compounded
Compounded semaglutide and compounded tirzepatide, both weekly injections. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing. Both molecules are sold on identical commercial terms, which is unusual — tirzepatide normally carries a much larger premium over semaglutide than $34.
Pros and watch-outs
What we like
- Price stated as flat at every dose
- No membership fee charged outside the medication price
- Cancellation available at any time
- Tirzepatide sits only $34 above semaglutide
Watch-outs
- Both figures are sale prices rather than standing rates
- A single $299 former price is claimed for two different molecules
- Starting at leaves the ceiling unquantified
- The compounding pharmacy is not identified
Best for
Buyers who want tirzepatide without the usual premium over semaglutide.
Who should look elsewhere
Anyone who needs a price that is not contingent on a sale holding.
How Novi compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A tirzepatide price you can check
See SkinnyRx → - Bodybuilding Health+
A headline that is the monthly rate
See Bodybuilding Health+ → - Synergy Rx
Compounded and branded together
See Synergy Rx →
More GLP-1 sellers by price reviews: Goldspan HealthGood Girl RxGood Life MedsHarborHarmony Wellness ClinicHarper Meds
Evidence & trials · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of Novi’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is Novi $99 a month for semaglutide?
- That is the advertised rate, presented as a reduction from $299 and described as starting at rather than fixed. It is stated to hold at every dose and to carry no membership fee. A sale price is only as durable as the sale, so the $299 figure is the one to watch.
- Why is tirzepatide only $34 more than semaglutide?
- Novi prices both against the same $299 former rate, which compresses the gap to $34. Across this category tirzepatide usually commands a far larger premium, because the drug itself costs more to compound. A narrow gap favors a buyer who wants the dual-agonist molecule and would otherwise pay substantially more for it.
- Is there a membership or program fee?
- No. The medication price is stated to be the whole charge, with no membership billed alongside it. That matters because a fee charged outside the advertised price is the most common reason a headline figure understates what a buyer pays. Novi's figure is not reduced by that arrangement.
- Does the price change as the dose increases?
- No. Both molecules are stated to be flat at every dose, so a titration from a starting dose upward does not move the monthly charge. Dose-linked pricing is the second most common way a low opening figure stops describing the rest of a year. Novi does not use it.
- Is Novi expensive compared with other GLP-1 sellers by price providers?
- Novi publishes a starting figure of $99/mo. Across the 226 GLP-1 sellers by price providers we review that publish a single monthly figure, those run $76 to $449 with a median of $179, which puts Novi below the median, toward the cheaper end. The other 11 GLP-1 sellers by price providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.